Affiliations 

  • 1 Ophthalmology UMERC, Universiti Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
  • 2 Ophthalmology, The University of Sydney, Sydney, New South Wales, Australia
  • 3 NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia
  • 4 Ophthalmology, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
  • 5 Opthalmology, UMERC, University of Malaya Eye Research Centre, Kuala Lumpur, Federal Territory of Kuala Lumpur, Malaysia
  • 6 Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Wilayah Persekutuan, Malaysia
  • 7 Ophthalmology, The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
BMJ Open Ophthalmol, 2021;6(1):e000626.
PMID: 33768163 DOI: 10.1136/bmjophth-2020-000626

Abstract

Objective: An ongoing third epidemic of retinopathy of prematurity (ROP) is contributed largely by developing nations. We describe a cohort of infants in a single neonatal unit where two limits of oxygen saturation were administered, to show real-world outcomes from trend in neonatology for higher oxygen to improve survival.

Methods and analysis: This retrospective, comparative study of prospectively collected data in an ROP screening programme included infants indicated by gestational age ≤32 weeks, birth weight <1501 g, ventilation for 7 days or requiring oxygen >1 month, who underwent dilated fundoscopic examination from age 4 weeks, every 2 weeks until full retinal vascularisation. Infants with ROP were examined weekly and treated where indicated. Data were divided into two epochs. Epoch 1 oxygen saturation targets were [88-92%], epoch 2 targets [90-95% (99%)] with allowance of increase to 20% for several hours after procedures. Outcome measures included development of ROP, treatment, mortality, sepsis and intraventricular haemorrhage.

Results: A total of 651 infants underwent examination between 2003 and 2016. The incidence of ROP in epoch 1 was 29.1% and epoch 2 was 29.3% (p=0.24). ROP progression doubled in epoch 2 (5 vs 11%, p=0.006), proportion of cases treated halved (14% vs 6%, p=0.0005), sepsis was halved (78.5% vs 41.2%, p<0.0001) and intraventricular haemorrhage doubled (20.2% vs 43.8%, p=0.0001) in epoch 2. Mortality was 4% and 0% in epochs 1 and 2, respectively.

Conclusion: Incidence of ROP did not differ, although ROP cases that worsened doubled with higher oxygen targets. ROP cases requiring treatment decreased, as did sepsis and mortality. Intraventricular haemorrhage cases doubled.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.